MSD Introduces VAXNEUVANCE™: The Pneumococcal Conjugate Vaccine Approved To Help Protect Pediatric & Adult Populations Against Invasive Pneumococcal DiseaseBased on the most recent statistics from the Department of Statistics Malaysia (DOSM), pneumonia ranks as the second leading cause of death, accounting for 13.3% across all age groups. In adults, pneumococcal disease presents differently, with pneumococcal pneumonia constituting the vast majority of death cases